Navigation Links
MITOCHONDRIAL DYSFUNCTION, VACCINES AND AUTISM: 1 in 50 Children Could Be at Risk
Date:3/28/2008

WILL THE GOVERNMENT CURB AN OVERLY AGGRESSIVE VACCINATION SCHEDULE TO COMBAT RISING AUTISM RATES?

NIXA, Mo., March 28 /PRNewswire-USNewswire/ -- Parents of children who regressed into autism after receiving vaccines are expressing cautious optimism that government health officials may at last be catching on to the link between vaccines and autism.

An article published on Huffington Post by investigative journalist David Kirby reported details of a conference call held earlier in March, bringing together federal vaccine safety officials to discuss concerns surrounding mitochondrial dysfunction, autism and vaccines.

The call came on the heels of a concession by the federal government that vaccines lead to regressive autism in nine-year-old Hannah Poling of Atlanta. The ruling is raising many questions, especially in the area of mitochondrial dysfunction, which the government conceded was exacerbated by Hannah's vaccines.

In the article, Kirby stated, "The hot topic of the day was mitochondria - the little powerhouses within each cell that convert food and oxygen into energy." And that, "Some researchers on the call reported that mitochondrial dysfunction is probably much more common than the current estimate of 1-in-4,000 people, making the potential implications for autism staggering."

Of utmost significance are the following points:

-- Up to 1 in 50 children (2%) may be at risk for mitochondrial dysfunction.

-- Thimerosal, mercury, aluminum, pollution, pesticides, medicines and prenatal alcohol exposure have all been shown to damage mitochondria.

-- Up to 20% of all children with autism may have underlying mitochondrial dysfunction.

-- The CDC is aware of this situation and is immediately taking measures to address the current national vaccine schedule.

-- The genetic susceptibility for mitochondrial dysfunction is not rare.

-- This DNA mutation alone may not be enough to confer cellular dysfunction; doctors believe there is an environmental trigger as well.

-- Children with mitochondrial dysfunction are more likely to regress into autism following a fever and illness from viral infections or a vaccine reaction.

-- Some changes in the vaccine schedule will almost surely be made. The most difficult decision is how and when to vaccinate children with proven mitochondrial dysfunction.

The National Autism Association (NAA), a parent-led non-profit organization, believes that vaccines have contributed to regressive autism in most children, and that the rise in autism correlates with the increase in vaccinations. "It's apparent that those in a position to bring the truth to light about the vaccine-autism connection might finally be listening to the parents who have witnessed it first-hand," said NAA board chair Scott Bono.

A meeting of the HHS National Vaccine Advisory Committee's Vaccine Safety Working Group will be held in Washington, DC on April 11th. This meeting will be open to the public.

To read Mr. Kirby's article, please visit:

http://www.huffingtonpost.com/david-kirby/the-next-big-autism-bomb_b_93 627.html.

To learn more about autism, visit: http://www.nationalautism.org.

CONTACTS:

Wendy Fournier (Portsmouth, RI) 401.835.5828

Rita Shreffler (Nixa, MO) 401.632.6452


'/>"/>
SOURCE National Autism Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Study looks at mitochondrial variation in sperm traits and sperm competitive ability
2. Mitochondrial bottleneck cracked
3. In silico modeling helps predict severity of mitochondrial disease
4. Single Mutation in Mitochondrial DNA Weakens Heart, Muscles
5. United Mitochondrial Disease Foundation Statement on Vaccines, Autism and Mitochondrial Disease
6. Human Papilloma Virus vaccines may decrease chances of oral cancer
7. CDC Study Links Thimerosal in Vaccines to Motor/Phonic Tics and Deficits in Attention, Behavior Control, Verbal IQ
8. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
9. Combination vaccines okay for infants, study shows
10. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
11. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: